V

ViroGates A/S
CSE:VIRO

Watchlist Manager
ViroGates A/S
CSE:VIRO
Watchlist
Price: 8.95 DKK 3.47%
Market Cap: 57.7m DKK
Have any thoughts about
ViroGates A/S?
Write Note

Intrinsic Value

VIRO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one VIRO stock under the Base Case scenario is 4.8 DKK. Compared to the current market price of 8.95 DKK, ViroGates A/S is Overvalued by 46%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VIRO Intrinsic Value
4.8 DKK
Overvaluation 46%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation Backtest
ViroGates A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VIRO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VIRO?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about ViroGates A/S

Provide an overview of the primary business activities
of ViroGates A/S.

What unique competitive advantages
does ViroGates A/S hold over its rivals?

What risks and challenges
does ViroGates A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ViroGates A/S.

Provide P/S
for ViroGates A/S.

Provide P/E
for ViroGates A/S.

Provide P/OCF
for ViroGates A/S.

Provide P/FCFE
for ViroGates A/S.

Provide P/B
for ViroGates A/S.

Provide EV/S
for ViroGates A/S.

Provide EV/GP
for ViroGates A/S.

Provide EV/EBITDA
for ViroGates A/S.

Provide EV/EBIT
for ViroGates A/S.

Provide EV/OCF
for ViroGates A/S.

Provide EV/FCFF
for ViroGates A/S.

Provide EV/IC
for ViroGates A/S.

Compare the intrinsic valuations
of ViroGates A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ViroGates A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of ViroGates A/S compared to its peers.

Compare the P/E ratios
of ViroGates A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing ViroGates A/S with its peers.

Analyze the financial leverage
of ViroGates A/S compared to its main competitors.

Show all profitability ratios
for ViroGates A/S.

Provide ROE
for ViroGates A/S.

Provide ROA
for ViroGates A/S.

Provide ROIC
for ViroGates A/S.

Provide ROCE
for ViroGates A/S.

Provide Gross Margin
for ViroGates A/S.

Provide Operating Margin
for ViroGates A/S.

Provide Net Margin
for ViroGates A/S.

Provide FCF Margin
for ViroGates A/S.

Show all solvency ratios
for ViroGates A/S.

Provide D/E Ratio
for ViroGates A/S.

Provide D/A Ratio
for ViroGates A/S.

Provide Interest Coverage Ratio
for ViroGates A/S.

Provide Altman Z-Score Ratio
for ViroGates A/S.

Provide Quick Ratio
for ViroGates A/S.

Provide Current Ratio
for ViroGates A/S.

Provide Cash Ratio
for ViroGates A/S.

What is the historical Revenue growth
over the last 5 years for ViroGates A/S?

What is the historical Net Income growth
over the last 5 years for ViroGates A/S?

What is the current Free Cash Flow
of ViroGates A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for ViroGates A/S.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ViroGates A/S

Current Assets 15.8m
Cash & Short-Term Investments 8.7m
Receivables 2.7m
Other Current Assets 4.4m
Non-Current Assets 176k
Other Non-Current Assets 176k
Current Liabilities 1.3m
Accounts Payable 541k
Other Current Liabilities 803k
Non-Current Liabilities 5.3m
Long-Term Debt 5.3m
Efficiency

Earnings Waterfall
ViroGates A/S

Revenue
5.3m DKK
Cost of Revenue
-1.6m DKK
Gross Profit
3.7m DKK
Operating Expenses
-17m DKK
Operating Income
-13.3m DKK
Other Expenses
197k DKK
Net Income
-13.1m DKK

Free Cash Flow Analysis
ViroGates A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VIRO Profitability Score
Profitability Due Diligence

ViroGates A/S's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

20/100
Profitability
Score

ViroGates A/S's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

VIRO Solvency Score
Solvency Due Diligence

ViroGates A/S's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Negative Net Debt
55/100
Solvency
Score

ViroGates A/S's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VIRO Price Targets Summary
ViroGates A/S

There are no price targets for VIRO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VIRO?

Click here to dive deeper.

Dividends

ViroGates A/S
does not pay dividends
Shareholder Yield

Current shareholder yield for VIRO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

ViroGates A/S

Country

Denmark

Industry

Health Care

Market Cap

57.7m DKK

Dividend Yield

0%

Description

ViroGates A/S develops and markets prognostic products for the healthcare sector. Its develops a product line suPARnostic, which measures the amount of amount of soluble urokinase Plasminogen Activator Receptor protein (suPAR) in human blood. The plasma level of suPAR reflects immune activation and is increased in such infectious diseases as HIV-1-infection, malaria, tuberculosis, Streptococcus pneumonia bacteraemia, sepsis, pneumococcal pneumonia and bacterial and viral CNS infection. Also, high suPAR levels are associated with increased inflammation, disease progression and risk of mortality. Thus, measuring suPAR levels serves as a marker to determine chances for survival upon hospital admission, as well as for monitoring for prevention of disease progression and earlier intervention time point. suPARnostic has two versions: Quantitative Point of Care Quick Triage test, which serves for patient triage in acute care, and Quantitative ELISA Assay that aims at clinical routine use.

Contact

Birkeroed
Banevaenget 13
+4521131336
www.virogates.com

IPO

2018-06-26

Employees

28

Officers

Chief Executive Officer
Mr. Jakob Knudsen
Co-Founder & Chief Scientific Officer
Dr. Jesper Eugen-Olsen
Chief Financial Officer
Ms. Josephine Baum Jorgensen
Vice President of Accounting
Ms. May Britt Dyvelkov
Vice President of Global Sales & Marketing
Mr. Thomas Krarup
Head of Marketing
David Stig Poulsen

See Also

Discover More
What is the Intrinsic Value of one VIRO stock?

The intrinsic value of one VIRO stock under the Base Case scenario is 4.8 DKK.

Is VIRO stock undervalued or overvalued?

Compared to the current market price of 8.95 DKK, ViroGates A/S is Overvalued by 46%.

Back to Top